|
Market Closed -
Nasdaq
04:00:00 2026-09-18 pm EDT
|
5-day change | 1st Jan Change | ||
| 9.950 USD | -0.30% |
|
+1.02% | +61.79% |
| Aug. 14 | ImmuCell Corporation, Q2 2026 Earnings Call, Aug 14, 2026 | |
| Aug. 13 | ImmuCell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 90.37M | - | - | - | - | - |
| 1,028B | |||||
| 651B | - | ||||
| 466B | |||||
| 346B | |||||
| 266B |
- Stock Market
- Stocks
- ICCC Stock
- Charts ImmuCell Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
